View Older Stories
-
Goldman: 'earnings revisions to drive upside in 19 names including ALL, LVS, META, TER and UNH'
-
Leerink on Bruker (BRKR): 'we see room for stock to grind higher as order book improves'
-
Bruker secures $25 million in European magnetic resonance system orders
-
Wolfe Research Upgrades Bruker (BRKR) to Outperform
-
Goldman Sachs Starts Bruker (BRKR) at Sell
-
Bruker acquires AST Revolution from Indaba Capital
-
Rothschild Redburn Starts Bruker (BRKR) at Buy
-
Bruker (BRKR) Declares $0.05 Quarterly Dividend; 0.5% Yield
-
Bruker (BRKR) PT Raised to $40 at Citi
-
Nephron Upgrades Bruker (BRKR) to Hold
-
Increasing unusual call option volume: BBD OS KMB VITL QURE CLPT SOYB BRKR
-
Bruker (BRKR) Tops Q3 EPS by 12c, cuts forecast
-
Bruker Q3 earnings preview: margin outlook, academic demand in focus
-
Bruker (BRKR) 2K of March 30 calls trade as share price up 1.9%
-
Bruker receives $10 million in federal NMR system orders
-
TD Cowen Reiterates Hold Rating on Bruker (BRKR)
-
Bruker (BRKR) PT Lowered to $40 at TD Cowen Amid 'Tough Demand Environment'
-
Bruker (BRKR) August 40 puts active
-
Bruker (BRKR) PT Lowered to $50 at JPMorgan
-
Bruker (BRKR) PT Lowered to $40 at Stifel
-
Bruker (BRKR) PT Lowered to $60 at Jefferies
-
Bruker (BRKR) PT Lowered to $43 at Barclays
-
Bruker (BRKR) Misses Q2 EPS by 10c ; Offers Guidance
-
Stifel Reiterates Hold Rating on Bruker (BRKR)
-
Bruker (BRKR) Applied MS Unveils Strategic Innovations
-
Bruker (BRKR) Announces Acquisition of biocrates
-
Bruker (BRKR) Launches New timsUltra AIP System
-
Bruker (BRKR) Launches Revolutionary timsOmniTM Mass Spectrometer
-
Bruker (BRKR) Launches Novel timsMetabo Mass Spectrometer
-
Bruker (BRKR) Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
-
Citi names 3 stocks as its new top picks in the Life Science sector
-
Citi Downgrades Bruker (BRKR) to Neutral
-
Bruker (BRKR) PT Lowered to $48 at Stifel
-
Bruker (BRKR) Tops Q1 EPS by 5c, Beats on Revenue; Offers FY25 Guidance
-
Bruker (BRKR) Announces First-of-a-kind 1.3 GHz High-Resolution NMR System
-
Bruker (BRKR) Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
-
Bruker (BRKR) Launches X4 POSEIDON Advanced X-Ray Microscope
-
Bruker (BRKR) Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
-
Bruker (BRKR) Appoints Laura Francis to its Board
-
Bruker (BRKR) Tops Q4 EPS by 2c; offers guidance
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Citi Reiterates Buy Rating on Bruker (BRKR)
-
BofA Securities Reiterates Buy Rating on Bruker (BRKR)
-
Bruker (BRKR) Comments on Delaware District Court’s Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products
-
U.S. District Court Awards 10x Genomics (TXG) Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
-
Guggenheim Starts Bruker (BRKR) at Buy
-
UBS Assumes Bruker (BRKR) at Neutral, ' Bucking the Broader Trend, but Prefer Better Entry Point'
-
Goldman Sachs Upgrades Bruker (BRKR) to Neutral
-
Bruker (BRKR) Introduces Dimension Nexus Atomic Force Microscope
-
Bruker (BRKR) spreader trades 5K contracts of December 47.50 and 55 puts

